enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today - AOL

    www.aol.com/abbvie-abbv-earnings-live-why...

    AbbVie offered up earnings guidance for the coming year of $12.12 to $12.32 per share that at the midpoint was well ahead of Wall Street's forecast of $12.13 per share. It also gave a long-term ...

  3. AbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom ...

    www.aol.com/abbvie-jumps-q4-earnings-beat...

    AbbVie Inc. (NYSE:ABBV) shares are trading higher on Friday. The company reported fourth-quarter adjusted earnings per share of $2.16, beating the street view of $2.11. Quarterly sales of $15.102 ...

  4. Is AbbVie Stock a Buy? - AOL

    www.aol.com/finance/abbvie-stock-buy-104800405.html

    Wake up with Breakfast news in your inbox every market day. ... Today, AbbVie's dividend payout ratio is 61% of 2024 earnings. That leaves plenty of room for future increases, but management may ...

  5. AbbVie (ABBV) Q4 2024 Earnings Call Transcript - AOL

    www.aol.com/finance/abbvie-abbv-q4-2024-earnings...

    Image source: The Motley Fool. AbbVie (NYSE: ABBV) Q4 2024 Earnings Call Jan 31, 2025, 9:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...

  6. AbbVie to bolster immunity illness drug pipeline with Landos deal

    www.aol.com/news/abbvie-bolster-immunity-illness...

    AbbVie has also agreed to pay Landos shareholders an additional up to $11.14 per share, or around $75 million in total, contingent on certain clinical development milestones.

  7. Why AbbVie (ABBV) Could Beat Earnings Estimates Again - AOL

    www.aol.com/news/why-abbvie-abbv-could-beat...

    AbbVie (ABBV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  8. FDA Approves AbbVie's Parkinson's Treatment, Medicare ... - AOL

    www.aol.com/finance/fda-approves-abbvies...

    For AbbVie, the 200-day moving average sits at $176.24, according to Benzinga Pro, which is below the current price of $189.49. For more on charts and trend lines, see a description here.

  9. Why Is AbbVie (ABBV) Up 12.7% Since Last Earnings Report? - AOL

    www.aol.com/news/why-abbvie-abbv-12-7-153003677.html

    For premium support please call: 800-290-4726 more ways to reach us